Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective
Year: 2021
Type: article
Abstract: The absence of 'shovel-ready' anti-coronavirus drugs during vaccine development has exceedingly worsened the SARS-CoV-2 pandemic. Furthermore, new vaccine-resistant variants and coronavirus outbreaks may occur in the near future, and we must be ready to face this possibility. However, efficient antiviral drugs are still lacking to this day, due to our poor understanding of the mode of incorporation and mechanism of action of nucleotides analogs that target the coronavirus polymerase to impair its essential activity. Here, we characterize the impact of remdesivir (RDV, the only FDA-approved anti-coronavirus drug) and other nucleotide analogs (NAs) on RNA synthesis by the coronavirus polymerase using a high-throughput, single-molecule, magnetic-tweezers platform. We reveal that the location of the modification in the ribose or in the base dictates the catalytic pathway(s) used for its incorporation. We show that RDV incorporation does not terminate viral RNA synthesis, but leads the polymerase into backtrack as far as 30 nt, which may appear as termination in traditional ensemble assays. SARS-CoV-2 is able to evade the endogenously synthesized product of the viperin antiviral protein, ddhCTP, though the polymerase incorporates this NA well. This experimental paradigm is essential to the discovery and development of therapeutics targeting viral polymerases.
Source: eLife
DOI: 10.7554/elife.70968
Authors: Mona Seifert, Subhas Chandra Bera, Pauline van Nies, Robert N. Kirchdoerfer, Ashleigh Shannon, Thi-Tuyet-Nhung Le, Xiangzhi Meng, Hongjie Xia, James M. Wood, Lawrence D. Harris, Flávia S. Papini, Jamie J. Arnold, Steven C. Almo, Tyler L. Grove, Pei-Yong Shi, Yan Xiang, Bruno Canard, Martin Depken, Craig E. Cameron, David Dulin
Institutions: Friedrich-Alexander-Universität Erlangen-Nürnberg, University of Wisconsin–Madison, Centre National de la Recherche Scientifique, Aix-Marseille Université, Architecture et Fonction des Macromolécules Biologiques, University of Iowa, National Institutes of Health, Delft University of Technology, The University of Texas at San Antonio Health Science Center, The University of Texas Medical Branch at Galveston, Victoria University of Wellington, Ferrier Research Institute, University of North Carolina at Chapel Hill, Albert Einstein College of Medicine, Institute for Protein Innovation, Vrije Universiteit Amsterdam
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,500
Funders: Amon G. Carter Foundation, Gilead Sciences, John S. Dunn Foundation, Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation, Sealy and Smith Foundation, Deutsche Forschungsgemeinschaft, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Ministry of Business, Innovation and Employment, National Institutes of Health, Centers for Disease Control and Prevention, Horizon 2020 Framework Programme, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Center for Advancing Translational Sciences, H2020 European Research Council
Awards: G1242293648, G1951091171, Regulation of Ebola virus replication by the host ubiquitin system, BaSyC - Building a Synthetic Cell, G3535678918, Developing small molecule inhibitors for modulating cytokine IL18 activities, G4494193945, Structural Studies of the Coronavirus Life Cycle, G4666712970, G4737300313, G5017364282, New Frontiers in Antiviral Development, G5530819787, Novel Strategies for the Discovery of Microbial Metabolic Pathways, G6047482813, Structural Studies of the Coronavirus Life Cycle, G7147529592, Structure function studies of a molecular complex for generating viral membrane, G7944295140, G9000050808, Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus, Coronavirus Genome Replication, Coronavirus RNA synthesis by multicomponent protein machines, RNA-dependent RNA Polymerase, UTMB Clinical and Translational Science Award
OpenAlex ID: W3202008685
